These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 33586999)
1. Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function. Hwang ME; Mayeda M; Shaish H; Elliston CD; Spina CS; Wenske S; Deutsch I Br J Radiol; 2021 Mar; 94(1119):20200433. PubMed ID: 33586999 [TBL] [Abstract][Full Text] [Related]
2. Neurovascular bundle-sparing radiotherapy for prostate cancer using MRI-CT registration: A dosimetric feasibility study. Cassidy RJ; Yang X; Liu T; Thomas M; Nour SG; Jani AB Med Dosim; 2016 Winter; 41(4):339-343. PubMed ID: 27745996 [TBL] [Abstract][Full Text] [Related]
3. Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes. Alongi F; Rigo M; Figlia V; Cuccia F; Giaj-Levra N; Nicosia L; Ricchetti F; Vitale C; Sicignano G; De Simone A; Naccarato S; Ruggieri R; Mazzola R Br J Radiol; 2021 Jan; 94(1117):20200848. PubMed ID: 33095659 [TBL] [Abstract][Full Text] [Related]
4. Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy. Cuccia F; Mazzola R; Nicosia L; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Vitale C; Mantoan B; De Simone A; Sicignano G; Ruggieri R; Cavalleri S; Alongi F Radiat Oncol; 2020 Jul; 15(1):178. PubMed ID: 32698843 [TBL] [Abstract][Full Text] [Related]
5. Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer. Ruggieri R; Naccarato S; Stavrev P; Stavreva N; Fersino S; Giaj Levra N; Mazzola R; Mancosu P; Scorsetti M; Alongi F Br J Radiol; 2015 Oct; 88(1054):20140736. PubMed ID: 26235142 [TBL] [Abstract][Full Text] [Related]
6. Dosimetric feasibility of stereotactic irradiation of primary prostate cancer at 5x9 Gy with a method of urethral sparing. Benhmida S; Beneux A; Udrescu C; Rouviere O; Horn S; Enachescu C; Lapierre A; Chapet O Br J Radiol; 2021 Nov; 94(1127):20210142. PubMed ID: 34283647 [TBL] [Abstract][Full Text] [Related]
7. Quantifying the impact of SpaceOAR hydrogel on inter-fractional rectal and bladder dose during 0.35 T MR-guided prostate adaptive radiotherapy. Farjam R; Mahase SS; Chen SL; Coonce M; Pennell RT; Fecteau R; Chughtai B; Dewyngaert JK; Kang J; Ch Formenti S; Nagar H J Appl Clin Med Phys; 2021 Sep; 22(9):49-58. PubMed ID: 34342134 [TBL] [Abstract][Full Text] [Related]
8. A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy. Hwang ME; Black PJ; Elliston CD; Wolthuis BA; Smith DR; Wu CC; Wenske S; Deutsch I Radiat Oncol; 2018 Oct; 13(1):192. PubMed ID: 30285812 [TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiotherapy using a hydrogel spacer for localized prostate cancer: A dosimetric comparison between tomotherapy with the newly-developed tumor-tracking system and cyberknife. Manabe Y; Hashimoto S; Mukouyama H; Shibamoto Y J Appl Clin Med Phys; 2021 Oct; 22(10):66-72. PubMed ID: 34415658 [TBL] [Abstract][Full Text] [Related]
10. Dominant intraprostatic lesion boosting in sexual-sparing radiotherapy of prostate cancer: A planning feasibility study. Ciabatti S; Ntreta M; Buwenge M; Gaudiano C; Sessagesimi E; Romani F; Angelini AL; Cammelli S; Macchia G; Deodato F; Zamagni A; Golfieri R; Morganti AG; Cilla S Med Dosim; 2019 Winter; 44(4):356-364. PubMed ID: 30955990 [TBL] [Abstract][Full Text] [Related]
11. Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer. Mazzola R; Sicignano G; Cuccia F; Vitale C; Rigo M; Giaj-Levra N; Nicosia L; Figlia V; Ricchetti F; Attinà G; Pastorello E; De Simone A; Gurrera D; Naccarato S; Ruggieri R; Alongi F Br J Radiol; 2021 Oct; 94(1126):20210521. PubMed ID: 34283646 [TBL] [Abstract][Full Text] [Related]
12. Feasibility of Same-Day Prostate Fiducial Markers, Perirectal Hydrogel Spacer Placement, and Computed Tomography and Magnetic Resonance Imaging Simulation for External Beam Radiation Therapy for Low-Risk and Intermediate-Risk Prostate Cancer. Brenneman RJ; Goddu SM; Andruska N; Roy A; Bosch WR; Fischer-Valuck B; Efstathiou JA; Gay HA; Michalski JM; Baumann BC Pract Radiat Oncol; 2022; 12(2):e117-e122. PubMed ID: 34695615 [TBL] [Abstract][Full Text] [Related]
13. Comparison of rectal dose reduction by a hydrogel spacer among 3D conformal radiotherapy, volumetric-modulated arc therapy, helical tomotherapy, CyberKnife and proton therapy. Saito M; Suzuki T; Sugama Y; Marino K; Sano N; Komiyama T; Aoki S; Maehata Y; Yoshizawa K; Ashizawa K; Suzuki H; Ueda K; Miyasaka Y; Araya M; Takahashi H; Onishi H J Radiat Res; 2020 May; 61(3):487-493. PubMed ID: 32211861 [TBL] [Abstract][Full Text] [Related]
14. Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer. Teunissen FR; Wortel RC; Wessels FJ; Claes A; van de Pol SMG; Rasing MJA; Meijer RP; van Melick HHE; de Boer JCJ; Verkooijen HM; van der Voort van Zyp JRN Clin Transl Radiat Oncol; 2022 Jan; 32():29-34. PubMed ID: 34825071 [TBL] [Abstract][Full Text] [Related]
15. [Dosimetric impact of hydrogel spacer use for stereotactic body radiotherapy of localised prostate cancer]. Ung M; Bossi A; Abbassi L; Vautier J; Anthonipillai V; Chevé M; Blanchard P Cancer Radiother; 2021 May; 25(3):237-241. PubMed ID: 33419606 [TBL] [Abstract][Full Text] [Related]
16. Neurovascular-Sparing MR-Guided Adaptive Radiotherapy in Prostate Cancer; Defining the Potential Population for Erectile Function-Sparing Treatment. Teunissen FR; van der Voort van Zyp JRN; Verkooijen HM; Wortel RC J Sex Med; 2022 Jul; 19(7):1196-1200. PubMed ID: 35618631 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of a rectal spacer with prostate SABR-first UK experience. King RB; Osman SO; Fairmichael C; Irvine DM; Lyons CA; Ravi A; O'Sullivan JM; Hounsell AR; Mitchell DM; McGarry CK; Jain S Br J Radiol; 2018 Feb; 91(1083):20170672. PubMed ID: 29182384 [TBL] [Abstract][Full Text] [Related]
18. Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trials. Jones RT; Hassan Rezaeian N; Desai NB; Lotan Y; Jia X; Hannan R; Kim DWN; Hornberger B; Dubas J; Laine AM; Zelefsky MJ; Timmerman RD; Folkert MR Med Dosim; 2017 Winter; 42(4):341-347. PubMed ID: 28774760 [TBL] [Abstract][Full Text] [Related]
19. Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison. Ogita M; Yamashita H; Nozawa Y; Ozaki S; Sawayanagi S; Ohta T; Nakagawa K Radiat Oncol; 2021 Jun; 16(1):107. PubMed ID: 34118956 [TBL] [Abstract][Full Text] [Related]
20. The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial. Nikitas J; Smith LM; Gao Y; Ma TM; Sachdeva A; Yoon SM; Jiang T; Low DA; Ballas LK; Steinberg ML; Cao M; Kishan AU Radiother Oncol; 2023 Jun; 183():109631. PubMed ID: 36934894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]